Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment

Choroidal Thickness Clinical Trial

Official title:

Choroidal Thickness Measurements During CSCR Treatment Applying EDI-OCT Technology

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01610804
• Other study ID #: CSCR2011
• Status: Completed
• Phase: N/A
• First received: May 31, 2012
• Last updated: June 1, 2012
• Start date: April 2011
• Est. completion date: May 2012

Study information

• Verified date: May 2012
• Source: University Hospital Regensburg
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT).

Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18
• Est. completion date: May 2012
• Est. primary completion date: November 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients with initial diagnosis of CSCR and no treatment so far

Exclusion Criteria:

• Therapy (drugs/laser) due to CSCR

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Central Serous Chorioretinopathy
• Choroidal Thickness

Locations

Country	Name	City	State
Germany	University Hospital Regensburg	Regensburg	Bavaria

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital Regensburg

Country where clinical trial is conducted

Germany, 

References & Publications (2)

Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009 Nov-Dec;29(10):1469-73. doi: 10.1097/IAE.0b013e3181be0a83. — View Citation

Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009 May;147(5):811-5. doi: 10.1016/j.ajo.2008.12.008. Epub 2009 Feb 20. — View Citation